Use access key #2 to skip to page content.
$71.82 2.63 (3.80%)
7/8/2008 4:00 PM

Celgene Corp (CELG)

CAPS Rating:
*****

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

View All Commentary (CELG)

Recs

0

Avatar nettersly (61.64) Submitted: 4/29/08 2:24 PM : Outperform Start Price: $64.56 CELG Score: -9.52

leader in biotech. i'm long.

Report this Post Replies: 0 | Reply

Featured Broker Partners